Con: Aprotinin has a good efficacy and safety profile relative to other alternatives for prevention of bleeding in cardiac surgery.
Beattie
W Scott
WS
Karkouti
Keyvan
K
D000933:Antifibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use; D007611:Aprotinin / Q000009:adverse effects / Q000627:therapeutic use*; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D006348:Cardiac Surgical Procedures; D002315:Cardiopulmonary Bypass; D006490:Hemostatics / Q000627:therapeutic use*; D006801:Humans; D051437:Renal Insufficiency / Q000209:etiology
D000933:Antifibrinolytic Agents; D006490:Hemostatics; D007611:Aprotinin